One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Focus on trials in dyslipidaemias, arrhythmias, cardiomyopathies, and interventional cardiology
Early vascular disease of Olympian Paavo Nurmi despite a healthy lifestyle
The ESC Textbook of Heart Failure: breaking the new educational frontier
Fasting vs. no fasting prior to catheterization laboratory procedures: the SCOFF trial
Fasting prior to percutaneous cardiovascular procedures: is it time to abandon this time-honoured practice?
Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study
Personalized clinical management of patients with atrial fibrillation: is a biomarker-based strategy for prediction of sinus rhythm persistence ready for prime time?
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial
Aspirin vs. clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial
STOPDAPT-3 one-year results support similar efficacy and safety of aspirin and clopidogrel after percutaneous coronary intervention
Glycoprotein IIb/IIIa inhibitors in acute myocardial infarction and angiographic microvascular obstruction: the REVERSE-FLOW trial
Bail-out glycoprotein IIb/IIIa inhibitors for coronary microvascular obstruction: guideline-indicated, but does harm outweigh benefit?
Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy
Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trials
Transcatheter correction of a rare combined anomalous pulmonary and systemic venous return in an adult
Fusion mixed reality: a novel approach to merge the physical and virtual cath lab
Weekly Journal Scan: increased incidence of acute myocardial infarction in patients with laboratory-confirmed influenza infection
